Bernard Schmidt

2.0k total citations
77 papers, 1.7k citations indexed

About

Bernard Schmidt is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Bernard Schmidt has authored 77 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cellular and Molecular Neuroscience, 28 papers in Molecular Biology and 27 papers in Pharmacology. Recurrent topics in Bernard Schmidt's work include Neuroscience and Neuropharmacology Research (26 papers), Cholinesterase and Neurodegenerative Diseases (25 papers) and Memory and Neural Mechanisms (16 papers). Bernard Schmidt is often cited by papers focused on Neuroscience and Neuropharmacology Research (26 papers), Cholinesterase and Neurodegenerative Diseases (25 papers) and Memory and Neural Mechanisms (16 papers). Bernard Schmidt collaborates with scholars based in Germany, France and United States. Bernard Schmidt's co-authors include Volker Hinz, F. Josef van der Staay, Joachim E. Schultz, Arjan Blokland, N. Gustke, Eckhard Mandelkow�, M. A. Kronforst-Collins, Jacek Biernat, Marc W. Kirschner and Helmut E. Meyer and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Biological Psychiatry.

In The Last Decade

Bernard Schmidt

73 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Schmidt Germany 25 754 687 462 337 304 77 1.7k
Rachel Brandeis Israel 25 695 0.9× 745 1.1× 448 1.0× 402 1.2× 447 1.5× 55 2.2k
Toshihiro Dohi Japan 28 1.2k 1.6× 1.3k 1.9× 224 0.5× 653 1.9× 122 0.4× 143 2.5k
Koji Hara Japan 25 615 0.8× 669 1.0× 145 0.3× 371 1.1× 367 1.2× 73 2.0k
Tomoyuki Nishizaki Japan 25 1.3k 1.7× 803 1.2× 240 0.5× 334 1.0× 125 0.4× 99 2.2k
Keith F. Martin United Kingdom 24 559 0.7× 1.0k 1.5× 314 0.7× 230 0.7× 164 0.5× 54 1.9k
Lynn Wecker United States 31 1.0k 1.4× 920 1.3× 367 0.8× 217 0.6× 217 0.7× 86 2.3k
T. Meert Belgium 20 445 0.6× 723 1.1× 183 0.4× 462 1.4× 128 0.4× 44 1.7k
Santina Chiechio Italy 29 820 1.1× 747 1.1× 217 0.5× 848 2.5× 136 0.4× 56 2.2k
Fèlix Junyent Spain 22 581 0.8× 409 0.6× 137 0.3× 302 0.9× 187 0.6× 48 1.4k

Countries citing papers authored by Bernard Schmidt

Since Specialization
Citations

This map shows the geographic impact of Bernard Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Schmidt more than expected).

Fields of papers citing papers by Bernard Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Schmidt. The network helps show where Bernard Schmidt may publish in the future.

Co-authorship network of co-authors of Bernard Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Schmidt. A scholar is included among the top collaborators of Bernard Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Schmidt. Bernard Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, Bernard, Eva Biewald, Nika Guberina, et al.. (2025). Functional outcome after Brachytherapy with bi-nuclide (Ru-106/Iodine-125) plaques in large uveal melanomas. Radiation Oncology. 20(1). 22–22.
2.
Boussoussou, Melinda, Milán Vecsey-Nagy, Márton Kolossváry, et al.. (2025). Comparative analysis of photon-counting and energy-integrating detector CT to identify obstructive coronary artery disease. European Radiology.
3.
Mohammadinejad, Payam, Eric C. Ehman, Sudhakar K. Venkatesh, et al.. (2019). Prior iterative reconstruction (PIR) to lower radiation dose and preserve radiologist performance for multiphase liver CT: a multi-reader pilot study. Abdominal Radiology. 45(1). 45–54. 6 indexed citations
4.
Scali, Carla, Fiorella Casamenti, Arianna Bellucci, et al.. (2002). Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats. Journal of Neural Transmission. 109(7-8). 1067–1080. 56 indexed citations
5.
Poindessous‐Jazat, Frédérique, et al.. (2000). Sustained effect of metrifonate on cerebral glucose metabolism after immunolesion of basal forebrain cholinergic neurons in rats. European Journal of Pharmacology. 387(2). 151–162. 6 indexed citations
6.
Ikonen, Sami, Bernard Schmidt, & Paavo Riekkinen. (1999). Characterization of learning and memory behaviors and the effects of metrifonate in the C57BL strain of mice. European Journal of Pharmacology. 372(2). 117–126. 12 indexed citations
7.
Staay, F. Josef van der, Richard J. Fanelli, Arjan Blokland, & Bernard Schmidt. (1999). Behavioral effects of apamin, a selective inhibitor of the SKCa-channel, in mice and rats. Neuroscience & Biobehavioral Reviews. 23(8). 1087–1110. 56 indexed citations
8.
Riekkinen, Paavo, Bernard Schmidt, & F. Josef van der Staay. (1998). Animal models in the development of symptomatic and preventive drug therapies for Alzheimer's disease. Annals of Medicine. 30(6). 566–576. 11 indexed citations
9.
Schmidt, Bernard & Roland Heinig. (1998). The Pharmacological Basis for Metrifonate’s Favourable Tolerability in the Treatment of Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 9(Suppl. 2). 15–19. 11 indexed citations
10.
Scali, Carla, Maria Grazia Giovannini, Luciano Bartolini, et al.. (1997). Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats. European Journal of Pharmacology. 325(2-3). 173–180. 82 indexed citations
11.
Riekkinen, Paavo, Bernard Schmidt, & Minna Riekkinen. (1997). Behavioral characterization of metrifonate-improved acquisition of spatial information in medial septum-lesioned rats. European Journal of Pharmacology. 323(1). 11–19. 13 indexed citations
12.
Höfner, Georg & Bernard Schmidt. (1996). Species differences in [3H]linopirdine (DuP 996) binding to brain membranes. European Journal of Pharmacology. 298(3). 307–312. 3 indexed citations
13.
Riekkinen, Paavo, et al.. (1996). Metrifonate improves spatial navigation and avoidance behavior in scopolamine-treated, medial septum-lesioned and aged rats. European Journal of Pharmacology. 309(2). 121–130. 38 indexed citations
14.
Jäkälä, Pekka, et al.. (1996). An indirect cholinesterase inhibitor, metrifonate, increases neocortical EEG arousal in rats. Neuroreport. 7(5). 1097–1101. 12 indexed citations
15.
Broqua, Pierre, Dominique Laude, Marie‐Thérèse Bluet‐Pajot, et al.. (1993). Are 5-HT<sub>1A</sub> Autoreceptors Involved in the Inhibitory Effect of Ipsapirone on Cold-Elicited Thyrotropin Secretion?. Neuroendocrinology. 57(4). 640–647. 4 indexed citations
16.
Beneke, Manfred, et al.. (1992). Neuroendocrine effects of ipsapirone on the hypothalamic-pituitary adrenal axis: CRF, ACTH and cortisol in healthy volunteers. European Journal of Clinical Pharmacology. 42(2). 163–169. 6 indexed citations
17.
Schmidt, Bernard, et al.. (1990). Evidence for a specific recognition site for tiflucarbine on calmodulin. European Journal of Pharmacology Molecular Pharmacology. 189(6). 411–418. 4 indexed citations
18.
Hirnle, P., et al.. (1990). Indications for radioisotope bone scanning in staging of cervical cancer. Archives of Gynecology and Obstetrics. 248(1). 21–23. 3 indexed citations
19.
Sladeczek, Fritz, Christopher J. Kirk, Joël Bockaert, & Bernard Schmidt. (1989). Non classical, multiple‐site interaction of [3H]‐prazosin with the α1‐adrenoceptor of intact BC3H1cells. British Journal of Pharmacology. 97(4). 1101–1110. 4 indexed citations
20.
Böhm, Michael, Reinhard Brückner, Ingelore Hackbarth, et al.. (1984). Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect.. Journal of Pharmacology and Experimental Therapeutics. 230(2). 483–492. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachel Brandeis Breakdown of academic impact, for papers by Toshihiro Dohi Breakdown of academic impact, for papers by Koji Hara Breakdown of academic impact, for papers by Tomoyuki Nishizaki Breakdown of academic impact, for papers by Keith F. Martin Breakdown of academic impact, for papers by Lynn Wecker Breakdown of academic impact, for papers by T. Meert Breakdown of academic impact, for papers by Santina Chiechio Breakdown of academic impact, for papers by Fèlix Junyent
Rankless by CCL
2026